Non-suicidal self-injurious behavior, endogenous opioids and monoamine neurotransmitters (scientific article)

Differential nociceptive deficits in patients with borderline personality disorder and self-injurious behavior: laser-evoked potentials, spatial discrimination of noxious stimuli, and pain ratings

Q33205200

Central mechanisms in pain

Q33673536

Opiate antagonists in children and adolescents

Q34120061

Self-destructive behavior in patients with dissociative disorders.

Q34153923

Raised plasma metenkephalin in patients who habitually mutilate themselves

Q34247613

The interpersonal dimension of borderline personality disorder: toward a neuropeptide model

Q34252326

Opioids in chronic pain

Q34430627

Non-suicidal self-injury among adolescents: diagnostic correlates and relation to suicide attempts.

Q34553994

The functions of deliberate self-injury: a review of the evidence

Q34570716

Dynorphin A activates bradykinin receptors to maintain neuropathic pain

Q34582923

Self-injury in Lesch-Nyhan disease

Q34727958

Self-injurious behavior and mood regulation in borderline patients

Q34741234

The dynorphin/kappa opioid receptor system: a new target for the treatment of addiction and affective disorders?

Q34903009

Long-term effects of childhood abuse on brain and neurobiology

Q35118867

The neurobiology of suicide and suicidality

Q35179139

State-dependent opioid control of pain

Q35811910

A review of prospective studies of biologic predictors of suicidal behavior in mood disorders

Q36687969

Immunoreactive β-Endorphin and Adrenocorticotropin in Human Cerebrospinal Fluid

Q37026840

Absence of opioid stress-induced analgesia in mice lacking beta-endorphin by site-directed mutagenesis

Q37626387

Endogenous Pain Control Systems: Brainstem Spinal Pathways and Endorphin Circuitry

Q40093729

Endogenous Opioids: Biology and Function

Q40141448

Pain experience related to self-injury in eating disorder patients

Q40307018

Stress-induced behavioral responses and multiple opioid systems in the brain

Q40543553

Relation of dissociative phenomena to levels of cerebrospinal fluid monoamine metabolites and beta-endorphin in patients with eating disorders: a pilot study

Q41067058

Low plasma immunoreactive beta-endorphin levels in autism

Q41890403

Behavioral and physiologic effects of CRH administered to infant primates undergoing maternal separation

Q42137796

Deliberate self-harm in people aged 60 years and over: characteristics and outcome of a 20-year cohort

Q42684257

Emotion regulation, coping and alcohol use as moderators in the relationship between non-suicidal self-injury and psychological distress

Q43285973

Stereoselective effect of morphine on antinociception and endogenous opioid peptide levels in plasma but not cerebrospinal fluid of dogs

Q43310926

Regional mu opioid receptor regulation of sensory and affective dimensions of pain

Q43673019

Measurement of CSF dynorphin a 1–8 immunoreactivity in anorexia nervosa and normal-weight bulimia

Q43889328

Norepinephrine release in the amygdala in response to footshock and opioid peptidergic drugs

Q44235506

Spinal kappa-opioid receptor-mediated antinociception is stimulus-specific

Q44240898

Autoradiographic evidence of delta-opioid receptor downregulation after prenatal stress in offspring rat brain

Q44329972

Increased density of mu-opioid receptors in the postmortem brain of suicide victims

Q44333119

Dynorphin promotes abnormal pain and spinal opioid antinociceptive tolerance.

Q44333127

Opioid antagonist effects on self-injury in adults with mental retardation: response form and location as determinants of medication effects.

Q44336949

Regionally selective increases in mu opioid receptor density in the brains of suicide victims

Q44338653

CSF neuropeptides in cancer pain: effects of spinal opioid therapy

Q44339600

Effect of opioid receptor antagonists on hypothalamic–pituitary–adrenal activity in rhesus monkeys

Q44341133

Autoradiographic evidence of mu-opioid receptors down-regulation after prenatal stress in offspring rat brain

Q44343018

Regulation of Human Affective Responses by Anterior Cingulate and Limbic µ-Opioid Neurotransmission

Q44343422

The mu-opioid receptor is necessary for [D-Pen2,D-Pen5]enkephalin-induced analgesia

Q44345741

Effects of naltrexone on learning and performance of conditional fear-induced freezing and opioid analgesia

Q44349733

Childhood trauma as a correlate of lifetime opiate use in psychiatric patients

Q44354277

Coping strategies moderate the relation of hypothalamus-pituitary-adrenal axis reactivity to self-injurious behavior

Q44785318

CSF beta-endorphins in childhood neuropsychiatric disorders

Q44914300

Cerebrospinal fluid and plasma beta-endorphin in combat veterans with post-traumatic stress disorder

Q45335205

Subtraction autoradiography of opiate receptor subtypes in human brain.

Q45999589

Deliberate self-harm in young people: characteristics and subsequent mortality in a 20-year cohort of patients presenting to hospital

Q46931632

Genetic, developmental and personality correlates of self-mutilation in depressed patients

Q46942569

Psychological, autonomic, and serotonergic correlates of parasuicide among adolescent girls

Q47299183

Pain assessment in self-injurious patients with borderline personality disorder using signal detection theory

Q47305348

Self-injurious behavior and serotonin in Prader-Willi syndrome

Q47307195

Proopiomelanocortin is the predominant adrenocorticotropin-related peptide in human cerebrospinal fluid

Q47567125

Hypothalamic-pituitary-adrenal axis response in borderline personality disorder without post-traumatic features

Q48221573

CSF beta-endorphin levels in pediatric neurologic disorders.

Q48388428

Prenatal stress alters the hypothalamic levels of methionine-enkephalin in pup rats

Q48422854

CSF beta-endorphin levels in patients with infantile autism

Q48747507

Prenatal stress has long-term effects on brain opiate receptors

Q49057799

Suicide among subjects with personality disorders.

Q51035079

The endogenous euphoric reward system that reinforces physical training: a mechanism for mankind's survival.

Q51091683

Naltrexone as a treatment for repetitive self-injurious behaviour:an open-label trial.

Q51113845

Effects of a microinjection of morphine into the amygdala on the acquisition and expression of conditioned fear and hypoalgesia in rats.

Q51122704

An inventory for assessing different kinds of hostility.

Q51361533

Cholecystokinin in human cerebrospinal fluid: concentrations, dynamics, molecular forms and relationship to fasting and feeding in health, depression and alcoholism.

Q51597837

Elevated pain thresholds correlate with dissociation and aversive arousal in patients with borderline personality disorder.

Q51775545

Improvement and recovery from suicidal and self-destructive phenomena in treatment-refractory disorders.

Q51873100

Chronic life stress alters sympathetic, neuroendocrine, and immune responsivity to an acute psychological stressor in humans.

Q52193800

Naloxone attenuates self-abusive behavior in developmentally disabled clients.

Q52270690

Clinical Correlates of Self-Mutilation Among Psychiatric Inpatients

Q58280652

Characterization and application of a radioimmunoassay for beta-endorphin using an antiserum with negligible cross-reactivity against beta-lipotropin

Q67281051

CSF beta-endorphin and dynorphin in bulimia nervosa

Q67519072

CSF metabolites in borderline personality disorder compared with normal controls

Q67666204

The effects of fenfluramine on suicidal behavior

Q68966958

Dynorphin A and related peptides administered intrathecally in the rat: a search for putative kappa opiate receptor activity

Q69885935

Risperidone antagonism of self-mutilation in a Lesch-Nyhan patient

Q71683816

Naltrexone and self-injurious behavior: a retrospective population study

Q71722885

Opiate antagonists and long-term analgesic reaction induced by inescapable shock in rats

Q72883547

Cessation of self-mutilation in a patient with borderline personality disorder treated with naltrexone

Q73122325

Increased adrenal androgen functioning in children with oppositional defiant disorder: a comparison with psychiatric and normal controls

Q73165828

Beta-endorphin and cortisol levels in plasma and CSF following acute experimental spinal traumas

Q73516997

Severity of reported childhood sexual abuse and its relationship to severity of borderline psychopathology and psychosocial impairment among borderline inpatients

Q74345945

Treatment of obsessive-compulsive cutting behavior with naltrexone

Q77327996

Self-injurious behavior in women with eating disorders

Q77705591

Using analog baselines to assess the effects of naltrexone on self-injurious behavior

Q78166017

P433

issue

1-2

P921

main subject

suicide

neurotransmitter

suicide prevention

suicide risk

page(s)

134-140

P577

publication date

2009-11-25

P1433

published in

Journal of Affective Disorders

Q15716493

P1476

title

Non-suicidal self-injurious behavior, endogenous opioids and monoamine neurotransmitters

P478

volume

124

Reverse relations

cites work (P2860)

Q42234820	A Google Trends-based approach for monitoring NSSI.
Q40785566	Accurately diagnosing and treating borderline personality disorder: a psychotherapeutic case.
Q47651877	Adolescents' Reward-related Neural Activation: Links to Thoughts of Nonsuicidal Self-Injury
Q48061985	Beyond medicalization: Self-injuring acts revisited
Q47279145	Borderline personality disorder features, emotion dysregulation and non-suicidal self-injury: Preliminary findings in a sample of community-dwelling Italian adolescents
Q39329510	Borderline personality disorder, mentalization, and the neurobiology of attachment
Q36443670	Borderline personality disorder: current drug treatments and future prospects.
Q38674947	Characterizing the course of non-suicidal self-injury: A cognitive neuroscience perspective
Q38596251	Conceptualizing the neurobiology of non-suicidal self-injury from the perspective of the Research Domain Criteria Project.
Q38916210	Early Childhood Environment and Genetic Interactions: the Diathesis for Suicidal Behavior
Q64119298	Emotional Pain Mediates the Link Between Preoccupied Attachment and Non-suicidal Self-Injury in High Suicide Risk Psychiatric Inpatients
Q89326880	Endogenous opioid system dysregulation in depression: implications for new therapeutic approaches
Q38444882	Identifying and managing nonsuicidal self-injurious behavior in the primary care setting
Q35948853	Improvement of nonsuicidal self-injury following treatment with antipsychotics possessing strong D1 antagonistic activity: evidence from a report of three cases
Q34259690	Is non-suicidal self-injury an "addiction"? A comparison of craving in substance use and non-suicidal self-injury.
Q28607353	Mechanisms of disturbed emotion processing and social interaction in borderline personality disorder: state of knowledge and research agenda of the German Clinical Research Unit
Q36244856	Naltrexone treatment reverses astrocyte atrophy and immune dysfunction in self-harming macaques.
Q38659366	Neuropathology of suicide: recent findings and future directions.
Q35361350	Neuropsychological Functions of μ- and δ-Opioid Systems
Q60021104	Nicht-suizidales selbstverletzendes Verhalten (NSSV) und Suizidale Verhaltensstörung (SVS) im DSM-5
Q30235216	Non-suicidal Self-Injury in Adolescence
Q45328802	Non-suicidal self-injury among psychiatric outpatient adolescent offspring of Croatian posttraumatic stress disorder male war veterans: Prevalence and psychosocial correlates
Q40082285	Nonsuicidal self-injury in adolescence: a clinical guideline for diagnostics and therapy
Q37984726	Oral self-injury: an update.
Q48248970	Pain perception in female adolescents with borderline personality disorder
Q34410324	Physical and social pains in borderline disorder and neuroanatomical correlates: a systematic review.
Q38562081	Possible role of a dysregulation of the endogenous opioid system in antisocial personality disorder
Q48063914	Potential relationship of self-injurious behavior to right temporo-parietal lesions
Q36202840	Predicting Persistence of Nonsuicidal Self-Injury in Suicidal Adolescents
Q53660295	Psychosocial Stress-Induced Analgesia: An Examination of Effects on Heat Pain Threshold and Tolerance and of Neuroendocrine Mediation.
Q26766469	The Addictive Model of Self-Harming (Non-suicidal and Suicidal) Behavior
Q58764755	The Experience of Pleasure: A Perspective Between Neuroscience and Psychoanalysis
Q46015033	The effects of acute tryptophan depletion on impulsivity and mood in adolescents engaging in non-suicidal self-injury.
Q42145112	The importance of communication in the management of postoperative pain
Q34252326	The interpersonal dimension of borderline personality disorder: toward a neuropeptide model
Q38372866	The relationship of psychological trauma and dissociative and posttraumatic stress disorders to nonsuicidal self-injury and suicidality: a review
Q41940141	The role of neuropeptides in suicidal behavior: a systematic review
Q37937304	Toward new avenues in the treatment of nonsuicidal self-injury
Q92940604	Understanding suicidal ideation and behaviour in individuals with chronic pain: a review of the role of novel transdiagnostic psychological factors
Q46717955	Variety of self-injury: is the number of different methods of non-suicidal self-injury related to personality, psychopathology, or functions of self-injury?